Please enter mandatory and valid details

Medical Advisory Board

Dr. Jiaoti Huang

Chair – Pathology
at Duke University

Read More
Dr. Jiaoti Huang

Chair - Pathology at Duke University

Dr. Jiaoti Huang earned his medical degree from Anhui Medical University in 1983 and a Master’s degree in Pharmacology from the Institute of Radiation Medicine in Beijing in 1986. He earned his PhD from New York University School of Medicine (1987-1990). He was a Leukemia Society of America Postdoctoral Fellow at NYU and Yale University. He did residency training in pathology at NYU School of Medicine and a fellowship in Oncologic Surgical Pathology at Memorial Sloan-Kettering Cancer Center. He became an assistant professor at the University of Rochester in July 2000 and rose to the rank of full professor in 2007. Dr. Huang moved to UCLA in 2008 and came to Duke University at the beginning of 2016. He is currently Professor and Chairman of Department of Pathology, as well as Professor of Pharmacology and Cancer Biology at Duke University. He is also a member of the Duke Cancer Institute.

Dr. Huang is an expert surgical pathologist and prostate cancer researcher. His clinical expertise is in the pathologic diagnosis of genitourinary tumors. His research laboratory investigates the molecular mechanisms, biomarkers, imaging and novel therapies for advanced prostate cancer. His research laboratory is a leader in studying neuroendocrine differentiation of prostate cancer and molecular pathogenesis of prostatic small cell neuroendocrine carcinoma. Dr. Huang has published 200 research papers, review articles and book chapters. His research has been supported by the National Institutes of Health, Department of Defense Prostate Cancer Research Program, American Cancer Society, Prostate Cancer Foundation, and Stand Up to Cancer.

Dr. Thomas Montine

Chair – Pathology at Stanford University School of Medicine

Read More
Dr. Thomas Montine

Chair – Pathology at Stanford University School of Medicine

Dr. Montine received his education at Columbia University (BA in Chemistry), the University of Rochester (PhD in Pharmacology), and McGill University (MD and CM). His postgraduate medical training was at Duke University, and he was junior faculty at Vanderbilt University where he was awarded the Thorne Professorship in Pathology. In 2002, Dr. Montine was appointed as the Alvord Endowed Professor in Neuropathology and Director of the Division of Neuropathology at the University of Washington. He was Director of the University of Washington Alzheimer’s Disease Research Center, one of the original 10 Centers in the US, and passed that responsibility to able colleagues. In 2010, Dr. Montine was appointed Chair of the Department of Pathology at the University of Washington. In 2016, Dr. Montine was appointed Chair of the Department of Pathology at Stanford University and the Stanford Medicine Endowed Professor in Pathology.

Dr. Montine is the founding Director of the Pacific Udall Center, one of 9 NINDS-funded Morris K. Udall Centers of Excellence for Parkinson’s Disease Research. Dr. Montine is among the top recipients of NIH funding for all Department of Pathology faculty in the United States.

Dr. Jayanta (Jay) Debnath

Chair – of Pathology at the University of California, San Francisco.

Read More
Dr. Jayanta (Jay) Debnath

Chair – of Pathology at the University of California, San Francisco.

Dr. Jayanta (Jay) Debnath is Distinguished Professor and Chair of Pathology at the University of California, San Francisco and a member of the UCSF Helen Diller Family Comprehensive Cancer Center, Bakar Immuno-X and Bakar Aging Research Institute. He received his M.D., magna cum laude, from Harvard Medical School, followed by residency training at the Brigham and Women’s Hospital Department of Pathology. Dr. Debnath is board certified in anatomic pathology. He then completed post-doctoral training at the Harvard Medical School Department of Cell Biology with Prof. Joan Brugge, where he became widely known for his studies of oncogene regulation of cell death and autophagy using three-dimensional (3D) organotypic culture systems. He joined the faculty at UCSF in 2005 and is internationally recognized for his expertise on the diverse cell biological roles of autophagy during cancer progression and metastasis. Dr. Debnath became Chair of Pathology at UCSF in 2018.

Dr. Debnath currently serves as Cancer Section Chief Editor of Autophagy, Editor of the Annual Reviews of Pathology and on the editorial board of Genes and Development. He also serves as an Editor of the 11th Edition of Robbins, Cotran and Kumar Pathologic Basis of Disease, the cornerstone introductory textbook in pathology whose next edition will be published in 2025. He has previously served as Chair of the Programmatic Review Panel for the Department of Defense Breast Cancer Research Program (2018-19) and Chair of the Tumor Cell Biology Study Section for NIH (2016-18). His honors include the HHMI Early Career Award for Physician Scientists (2006), DOD Breast Cancer Research Program Era of Hope Scholar Award (2011), American Society of Cell Biology Keith Porter Mid-Career Investigator Award (2016), Ramzi Cotran Memorial Lectureship from Brigham and Women’s Hospital, Harvard Medical School (2019), and American Society of Investigative Pathology Outstanding Investigator Award (2021). He has been elected into membership in the American Society of Clinical Investigation (2013), American Association of Physicians (2023), and Association of University Pathologists (Pluto Society, 2024)